Data cannot be made publicly available due to ethical and legal restrictions on patient-level data. Requests for the data should be sent to The Chinese Medical Association at their website (<http://www.cma.org.cn/ensite/index/Contact_us/index.html>) or to Ling Luo, Deputy Secretary - General of the Chinese Medical Association (<intl@cma.org.cn>).

Introduction {#sec001}
============

In 2015, there were about 1.4 billion people in China, accounting for about a fifth of the world population\[[@pone.0169970.ref001]\]. According to the [2010 census](https://en.wikipedia.org/wiki/Sixth_National_Population_Census_of_the_People%27s_Republic_of_China), there was about 15.9 million live births in China, with a crude birth rate of 11.9 births per 1,000 total population\[[@pone.0169970.ref002]\]. The report from the United Nations inter-agency group for child mortality estimation shows that neonatal mortality rates in China were 30 deaths per 1,000 live births in 1990, and 6 deaths per 1,000 live births in 2015\[[@pone.0169970.ref003]\]. Furthermore, data show that an almost 80% decline in premature mortality in children between 1990 and 2010\[[@pone.0169970.ref004]\], a 62% decrease in neonatal mortality between 1996 and 2008, and an improved international neonatal mortality standing. However, there were large discrepancies in neonatal mortality rates between urban and rural counties, and the three main diseases of birth asphyxia, preterm birth complications, and congenital abnormalities accounted for 64% of deaths in neonates in China during 2008\[[@pone.0169970.ref005]--[@pone.0169970.ref007]\].

It is well established that the decrease in neonatal mortality is explained by a number of intersecting factors such as politics, economics, culture and health beliefs, training and medical practice; nonetheless, advances in neonatal medicine are likely key elements of this trend. National surveys of neonatal medicine are therefore needed to inform neonatal health care policy and practice. National surveys of this kind have been conducted such as in America\[[@pone.0169970.ref008]\], and Canada\[[@pone.0169970.ref009]\]. In China, two national surveys on the situation of hospitalized neonates\[[@pone.0169970.ref010]\] and on the neonatal intensive care units (NICU)\[[@pone.0169970.ref011]\], have contributed to the development of guidelines on the structure and organization of neonatal wards\[[@pone.0169970.ref012]\]. There are also a number of reviews and retrospective studies of neonatal medicine\[[@pone.0169970.ref013], [@pone.0169970.ref014]\], and surveys on the morbidity and mortality of neonatal respiratory failure at the Chinese national level\[[@pone.0169970.ref015], [@pone.0169970.ref016]\]. However, there is still a need for more comprehensive studies that gather data on issues such as staffing, investment, health care practice, and health care costs, which are key to health policy decision-making.

Given China's population, the country's progress in neonatal medicine, the data and insight gathered from this experience can inform efforts to improve child health worldwide\[[@pone.0169970.ref017]\]. Comprehensive data on neonatal medicine in China will also help to explain the important decrease in child mortality in China in recent years\[[@pone.0169970.ref018], [@pone.0169970.ref019]\].

The present study seeks to answer two main questions: (1) from an international point of view, what detailed evidences or situations in China's experience in the practice of neonatal medicine explain the speedy decline of neonatal mortality? (2) from a national perspective, what are the situations or differences in neonatal medicine across regions and hospitals? For these purposes, we established a national dataset of neonatal medicine in China, by integrating comprehensive data on tertiary neonatal medicine in China over three consecutive years (2008, 2009 and 2010), including investment in neonatal health, workforce, health activities, and disease expenditure. This database may serve as a benchmark for future longitudinal and cross-sectional studies.

Methods {#sec002}
=======

Data sources {#sec003}
------------

We extracted data from documents submitted as part of a request for proposals issued in 2011 by The Ministry of Health of the People\'s Republic of China (MOH) for projects aiming to evaluate and develop national key clinical subspecialty indicators in mainland China. And the indicators included the data for three consecutive years (2008--2010). All applicants were required to provide information on their institutional infrastructure, workforce, health-care, research, and training activities. Given the availability of electronic medical record systems at Class A level III hospitals in China, the highest level serving as medical hubs and being responsible for providing specialist health services, medical education and research, database administrators of the hospitals were able to export objective data from hospital information system\[[@pone.0169970.ref020]\].

Of the 31 provincial districts in mainland China, three provinces (Shanxi, Hainan, and Tibet), accounting for 3.6% of population of mainland China and that were relatively underdeveloped with respect to socioeconomic and health\[[@pone.0169970.ref021]\], were absent from this application. In all, 61 newborn units in Class A level III provincial or ministerial hospitals (see [Fig 1](#pone.0169970.g001){ref-type="fig"} and [S1 Table](#pone.0169970.s001){ref-type="supplementary-material"}), affiliated with universities with the most advanced level in medicine, education and research within local areas, were included. The newborn units were located in 31 cities (including one national capital, and 27 provincial capitals) within 28 provincial districts, and represented key provincial clinical institutions of neonatal medicine. Given these characteristics, findings from the study reflect the performance of advanced neonatal medicine in mainland China.

![Distribution of 61 surveyed newborn units in China.\
Sixty-one surveyed newborn units were from Class A level III provincial or ministerial affiliated hospitals, distributed in 31 cities of 28 provincial districts among six geographical regions in mainland China. The units were from child hospital (CH), general hospital (GH), and maternal and child hospital (MCH). The city names, hospital types, newborn beds, and newborn bed-population ratios (number in the brackets, for every 100,000 population) were marked respectively. The adapted map is for illustrative purposes only, originally from the free maps website (<http://www.d-maps.com/carte.php?num_car=11572&lang=en>).](pone.0169970.g001){#pone.0169970.g001}

Procedures {#sec004}
----------

Proposals submitted in response to the request for proposals, and commitments of data authenticity were included in the study. Accepted proposals were then reviewed by representatives of provincial departments of health. All proposals accepted at this first stage of review were then forwarded to the Chinese Medical Association for further review and selection. Announced and posted by Chinese Medical Association on its official website, proposals were also opened to professionals and the public for data authenticity.

The study was not a random sampling survey, and we retrospectively extracted data from the 61newborn units in 2014 and 2015. To ensure data quality, related references such as the database of China National Knowledge Infrastructure, National Natural Science Foundation of China, Science Citation Index, MEDLINE/PubMed resources, and hospital websites, were searched. Furthermore, the corresponding author had access to individual hospital information during and after data collection.

Indicators {#sec005}
----------

We examined tertiary neonatal data for the years 2008, 2009, and 2010, including newborn health infrastructure, workforce, health service, and disease expenditure.

Data on newborn health infrastructure and workforce were the situation at the end of 2010. According to the National Bureau of Statistics of China, all provinces and municipalities are classified into six geographical regions (North China, Northeast China, East China, South Central China, Southwest China, and Northwest China). In China, the majority of newborn medical services are offered by children's hospitals (CH), general hospitals (GH), and maternal and child hospitals (MCH), and the data were collected by year, type of hospital, and city or region.

Available newborn beds were the number of beds registered at health authorities. Investments on newborn units primarily represented the money for the purchase of medical equipment, scientific research, personnel training, and newborn ward reconstruction, and excluded the salary of staff. Health workforce included full-time professionals with certificates issued by The Ministry of Health of China, and each was just able to practice at a single hospital, having no authority to practice in other hospital wards. The workforce did not include people in training such as interns, trainee nurses, fellows, and ward care workers. Health professionals consisted of physicians (including chief physicians, deputy chief physicians, attending physicians, and resident physicians), and nurses (including chief nurses, associate chief nurses, [nurse-in-charge](http://www.iciba.com/nurse-in-charge)s, and primary nurses). Given that physician assistants, respiratory therapists, physiotherapists, pharmacists, and nutritionists are rare in newborn units in China, we excluded them for this investigation. The physician-to-bed ratio, nurse-to-bed ratio, and ratio of nurses to physicians were calculated in this study.

Diseases were classified according to the International Classification of Diseases, 9th Revision (ICD-9). Discharged patients were the number of sick newborns' admission registrations at Hospital Inpatient Management System, and all deceased inpatients were counted as discharges. Length of hospital stay was defined as the number of nights the sick newborn remained in the hospital for his or her stay, and length of hospital stay for a particular disease in a hospital was calculated by dividing the sum of inpatient days by the number of patient admissions with the same [diagnosis](https://en.wikipedia.org/wiki/Diagnosis-related_group) classification\[[@pone.0169970.ref022]\]. The number of patients who died in hospital, was small compared to overall discharges, and they were excluded for the calculation of length of stay. The definition of nosocomial infection was the same as that used by the Centers for Disease Control and Prevention\[[@pone.0169970.ref023]\].

Because disease spectrums were different across hospitals, and the numbers of discharged extremely low birth weight (ELBW) infants (Birth weight \<1,000 grams) were missing for some hospitals, we chose typical parameters and diseases for the analysis of disease expenditure. For survival rate of ELBW infants, we calculated the percentage from five hospitals in 2010, where each unit had more than 20 discharged ELBW infants reported yearly. Based on clinical system, X-ray and laboratory examination, the diagnostic criteria of respiratory distress syndrome (RDS), pneumonia, and sepsis, were according to Chinese textbook of Practice of Neonatology (Third edition)\[[@pone.0169970.ref024]\], and they were similar to the ones in The Merck Manuals\[[@pone.0169970.ref025]--[@pone.0169970.ref027]\].

Disease specific medical expenditure was estimated as the cost of principal discharge diagnosis for a hospital stay, regardless of other diagnoses, charged to a hospital finance department for newborn care, not including the cost for parents' inpatient care. The value of the Chinese Yuan (CNY) (Renminbi) was adjusted to United States Dollars (USD) using the consumer price index (1 USD = 6.623 CNY on December 30, 2010).

The ratio of hospital cost to per capita disposable income of urban residents was calculated by dividing disease-specific medical expenditure by per-capita disposable income of local urban residents. The ratio of hospital cost to per-capita health expenditure of urban residents was calculated by dividing disease-specific medical expenditure by local per-capita health expenditure. The data on disposable income of local urban residents, and per-capita health expenditure of local urban residents in China were obtained from the China Statistical Yearbook 2013\[[@pone.0169970.ref028]\].

Analysis {#sec006}
--------

First we conducted descriptive statistics to explore the distribution and frequencies of results. Given the non-normal distributions of variables, the descriptive parameters reported are the median, interquartile range (IQR), range (minimum and maximum), and sum if necessary. Then we conducted Independent-Samples Nonparametric Test for variables with non-normal distribution. Post hoc analysis, such as pairwise comparison, was omitted, because our main purpose was to establish a national baseline database. Data were analyzed using The Statistical Package for Social Sciences (SPSS, version 23.0).

Results {#sec007}
=======

Available newborn beds {#sec008}
----------------------

Of the 61 newborn units in Class A level III provincial or ministerial hospitals, 20 were CHs, 29 were GHs, and 12 were MCHs. The newborn units were located in 31 cities, six regions within China ([Fig 1](#pone.0169970.g001){ref-type="fig"}). There was a wide range (20--260 beds) in the number of newborn beds across the hospitals (median = 62 \[IQR 43--110\]) at the end of 2010. South Central China had the highest proportion of newborn beds (31%), followed by East China (28%), North China (13%), Southwest China (11%), Northeast China (9%), and Northwest China (8%). The proportion of newborn beds in CH, GH and MCH were 44%, 33% and 24% respectively ([Table 1](#pone.0169970.t001){ref-type="table"}).

10.1371/journal.pone.0169970.t001

###### Newborn unit investment, workforces and health care activities in 61 hospitals during 2008--2010.

![](pone.0169970.t001){#pone.0169970.t001g}

                                                        Median   IQR            Range        Sum
  ----------------------------------------------------- -------- -------------- ------------ ---------
  Available newborn beds in 2010                        62       43--110        20--260      4,948
   Child hospital (*n* = 20)                            100      73--143        40--200      2,167
   General hospital (*n* = 29)                          50       37--60         20--150      1,617
   Maternal & Child hospital (*n* = 12)                 85       64--114        32--260      1,164
  Investment (1000 US\$)                                345      166--586       11--3,510    83,622
   2008                                                 302      151--508       29--3,510    27,995
   2009                                                 318      170--586       11--2,225    26,137
   2010                                                 364      180--695       18--1,812    29,490
  Number of physicians with degree in 2010              22       15--29         8--44        1,369
   PhD                                                  3        1--8           0--20        279
   Master Degree                                        9        6--15          0--29        686
   Bachelor Degree                                      5        2--10          0--23        394
  Number of nurses with degree in 2010                  52       33--81         12--126      3,443
   PhD                                                  0        0--0           0--1         2
   Master Degree                                        0        0--1           0--5         40
   Bachelor Degree                                      16       10--27         3--74        1,272
   College                                              31       18--45         1--101       2,129
  Discharged inpatients                                 2,284    1,266--3,522   438--7,530   465,629
   2008                                                 2,158    1,169--3,301   438--5,434   142,434
   2009                                                 2,327    1,234--3,659   532--6,409   153,036
   2010                                                 2,612    1,436--3,804   616--7,530   170,159
  Length of hospital stay for overall newborns (Days)   9.5      8.2--10.8      4.2--17.5    
   2008                                                 9.7      8.3--11.4      4.2--14.8    
   2009                                                 9.5      8.2--10.5      5.2--16.8    
   2010                                                 9.3      7.9--10.6      4.9--17.5    
  Inpatient antimicrobial drug use rate (%)             68.7     49.8--87.0     11.5--100    
   2008                                                 70.5     52.8--88.5     15.2--100    
   2009                                                 69.9     53.9--85.8     14.5--100    
   2010                                                 65.0     44.4--85.6     11.5--100    
  Nosocomial infection rate (%)                         3.2      1.7--5.4       0.0--14.9    
   2008                                                 3.2      2.0--5.5       0.1--14.9    
   2009                                                 3.1      1.7--5.4       0.0--12.0    
   2010                                                 3.1      1.6--5.3       0.0--12.1    

IQR, Interquartile range; Range (minimum-maximum)

Investments on newborn units {#sec009}
----------------------------

During 2008--2010, there was an overall US\$83.6 million investment in the newborn units. The median yearly investment for a single newborn unit was US\$344,700 (IQR166,100--585,800). MCHs invested more than CHs and GHs (*P* = 0.016), and the median yearly investments for MCH, CH and GH were US\$475,200 (IQR 181,200--742,100), US\$413,000 (IQR 236,200--659,200), and US\$245,600 (IQR 151,000--456,100) respectively.

Newborn health workforce {#sec010}
------------------------

The median number of physicians per newborn unit was 22 (IQR 15--29), with a total of 1,369 across the 61 hospitals. There were more physicians in CHs (median = 26, IQR 22--35) (*P* = 0.027), followed by MCHs (median = 22, IQR17-33) and GHs (median = 15, IQR 12--25). The proportions of chief physicians, deputy chief physicians, attending physicians, and resident physicians were 19.4% (265), 19.4% (266), 28.9% (396) and 32.3% (442), respectively. There were significant differences in job titles across regions (*P* = 0.040) and hospital types (*P\<*0.001).

Among all physicians, 20.4% (279) had M.D/PhD degrees. Physicians with the degree of Master of Medicine shared 50.1% (686). There were significant differences in academic attainment for physicians across hospital types (*P\<*0.001), but not across regions. 30% (153) of physicians had M.D/PhD degrees in GH, while 15% (85) in CH and 15% (41) in MCH.

Our results showed that there were 3,443 nurses in the newborn units, and the nurse-to-bed ratio was 0.70 (1: 1.44). No significant differences in nurse-to-bed ratio were found across regions and hospital types. The median of nurses per unit was 52 (IQR 33--81). Only 2.6% (90) of nurses had senior job titles (chief nurse, and associate chief nurse), and 80.8% (2,782) of nurses were in junior positions. The majority (61.8%) of nurses were trained at the college level and only two nurses had a PhD degree, and 42 nurses had a Master's degree. No significant differences in academic attainment for nurses were found across regions and hospital types.

Overall, the physician-to-nurse ratio was 0.4(1: 2.51), and the physician-to-bed ratio was 0.27 (1:3.61).

Inpatient discharges and length of hospital stay {#sec011}
------------------------------------------------

During 2008--2010, there was a total discharge of 465,629 newborn inpatients, and the overall inpatient discharges increased by 19.5%. In 2010, the median inpatient discharges in newborn units were 2,612 cases (IQR 1,436--3,804), and one physician annually discharged 117 (IQR 81--164) inpatients, and one nurse care about 48 (IQR 38--60) inpatients. The median length of hospital stay for overall inpatient newborns was 9.5 (IQR 8.2--10.8) days (see [Table 1](#pone.0169970.t001){ref-type="table"}). And the median length of hospital stay depended on the type of condition: 14.04 (IQR 11.0--16.8) days for preterm infants (less than 37 weeks' gestation); 22.6 (IQR 15.3--31.0) days for very low birth weight (VLBW) infants (Birth weight \<1,500 grams) ([Table 2](#pone.0169970.t002){ref-type="table"}).

10.1371/journal.pone.0169970.t002

###### Disease expenditure of a single hospital stay for common newborn diseases during 2008--2010.

![](pone.0169970.t002){#pone.0169970.t002g}

                        Length of hospital stay (Days)   Daily cost (US Dollars)   Hospital cost (US Dollars)                                                                                                                         
  --------------------- -------------------------------- ------------------------- ---------------------------- ------------ ------------ ------------ ------------ -------------- ---------------- ---------------- ---------------- ---------
  North China           8.6                              14.0                      14.3                         14.8         124          112          194          153            1,046            1,714            2,540            2323
  (7.3--10.3)           (10.5--15.6)                     (10.1--25.6)              (8.4--21)                    (117--155)   (104--184)   (141--272)   (124--206)   (871--1,423)   (1,045--2,577)   (1,541--4,989)   (1,028--4,440)   
  Northeast China       7.5                              10.1                      10.2                         21.5         98           124          151          152            750              1,242            1,474            2,842
  (7--8.3)              (9.6--10.6)                      (9--14)                   (14.8--25.6)                 (85--111)    (120--135)   (128--223)   (129--193)   (675--804)     (1,146--1,432)   (1,206--2,424)   (2,518--3,329)   
  East China            9.0                              14.0                      16.3                         30.0         95           92           139          128            820              1,161            2,647            3,540
  (7.3--10.3)           (11.3--15.1)                     (12.5--22.3)              (21--36.1)                   (70--102)    (75--115)    (107--189)   (109--157)   (642--1,078)   (945--1,548)     (2,353--3,166)   (3,058--4,833)   
  South Central China   10.2                             14.8                      16.7                         31.4         102          136          174          162            1,113            1,858            3,518            4,630
  (8.3--13.4)           (13.7--17.3)                     (13.1--23.6)              (24.4--35.8)                 (75--136)    (90--157)    (154--229)   (113--207)   (749--1,426)   (1,401--2,603)   (2,613--4,227)   (2,605--6,571)   
  Southwest China       9.3                              10.4                      11.6                         15.3         99           118          171          134            819              1,046            2,461            2,023
  (7.4--10.9)           (9.5--15.1)                      (8.5--16.1)               (13.1--18.1)                 (79--116)    (86--128)    (120--293)   (102--154)   (697--1,043)   (890--1,684)     (1,275--2,862)   (1,405--2,579)   
  Northwest China       9.0                              11.5                      12.0                         15.1         99           138          174          151            681              1,550            1,891            1,963
  (5--11.5)             (9.1--15.9)                      (10--14.2)                (11.7--20.1)                 (82--125)    (96--148)    (135--212)   (99--192)    (499--1,201)   (1,269--1,639)   (1,480--2,253)   (1,397--3,586)   
  Over all              9.0                              14.0                      14.3                         22.6         99           109          164          141            856              1,369            2,575            3,306
  (7.4--10.8)           (10.9--15.3)                     (11--20.0)                (15.3--31.0)                 (84--119)    (88--136)    (128--222)   (114--185)   (682--1,162)   (1,044--1,767)   (1,619--3,516)   (2,048--4,629)   
  *P*-value             0.008                            0.114                     0.002                        \<0.001      0.006        0.005        0.137        0.393          \<0.001          0.008            \<0.001          \<0.001

*P*-values were the probabilities compared across six regions within China; Interquartile ranges in the brackets were marked respectively. RDS, Respiratory distress syndrome; VLBW, Very low birth weight (Birth weight \<1,500 grams).

Nosocomial infection and use of antibiotics in hospitalized patients {#sec012}
--------------------------------------------------------------------

During 2008--2010, nosocomial infection rates (median = 3.2% \[IQR 1.7--5.4\]) varied largely across the hospitals, and at one GH, the hospital infection rate peaked to 14.9% (see [Table 1](#pone.0169970.t001){ref-type="table"}). No significant differences in nosocomial infection rate were found across hospital types and regions. However, the use of antibiotics was significant different across hospital types (*P* = 0.025) and regions (*P* = 0.008). Overall, about two-thirds (median = 68.7% \[IQR 49.8--87.0\]) of newborns received antibiotics during their stays in hospital, and the median in CHs (median = 81.0% \[IQR 49.6--92.1\]) was higher than GHs (median = 65.0% \[IQR 51.9--76.9\]) and MCHs (median = 67.9% \[IQR 36.8--89.4\]). Over the three years, the nosocomial infection remained same, and the use of antibiotics in hospitalized patients dropped by 5.5% ([Table 1](#pone.0169970.t001){ref-type="table"}).

Cutting-edge neonatal technologies and quality {#sec013}
----------------------------------------------

Advanced incubators and ventilators, cardio-respiratory monitors, magnetic resonance imaging, and cardiac echocardiography, were commonly reported in most of the hospitals. Four hospitals in Hangzhou, Shanghai, and Guangzhou, used extracorporeal membrane oxygenation technology to care for the 17 sickest newborns during 2007--2010. Surgical repair of serious congenital cardiac malformations, complex thoracoabdominal surgery, minimally invasive surgery of gastrointestinal malformations, and hemodialysis were offered at several hospitals.

Disease expenditure {#sec014}
-------------------

During the three years, the length of hospital stay, daily cost, and hospital cost for common newborn diseases of pneumonia, sepsis, RDS, and VLBW infants, were specifically reported, and they all varied significantly across regions ([Table 2](#pone.0169970.t002){ref-type="table"}), but not across hospital types. And for these diseases, the ratios of median hospital cost to per-capita disposable income of local urban residents, and ratios of median hospital cost to per-capita health expenditure of local urban residents, were significantly different across regions ([Fig 2](#pone.0169970.g002){ref-type="fig"}).

![Disease expenditures of four common newborn diseases by regions during 2008--2010.\
(A) Median hospital costs by regions, and the *P*-values were all less than 0.001for regional comparisons of pneumonia, sepsis, RDS, and VLBW infants. (B) Ratios of median hospital cost to per-capita disposable income of local urban residents by regions, and the *P*-values for regional comparisons of pneumonia, sepsis, RDS, and VLBW infants were 0.237, 0.026, 0.003, and 0.092 respectively. (C) Ratios of median hospital cost to per-capita health expenditure of local urban residents by regions, and the *P*-values for regional comparisons of pneumonia, sepsis, RDS, and VLBW infants were 0.111, 0.001, less than 0.001, and less than 0.001 respectively.](pone.0169970.g002){#pone.0169970.g002}

Extremely low birth weight (ELBW) infants {#sec015}
-----------------------------------------

During 2008--2010 in the five hospitals in four cities (Shenyang, Shanghai, Changsha, and Tianjin), the lightest infant who survived had a birth weight of 500 grams\[[@pone.0169970.ref029]\], but no infant with a gestation age of less than 25 weeks survived during this period. The median length of hospital stay, daily cost, and hospital cost for a single stay of hospital were 49.0 days (IQR 45.0--58.2), US\$172 (IQR 148--196) and US\$8,613 (IQR 8,153--9,216), respectively, and the survival rate of ELBW infants was 76.0% (259/341).

Our data also showed that the treatment of ELBW infants presented economic consequences to parents. Overall, the median hospital cost of ELBW infants for a single hospital stay was 3.0 times (IQR 2.0--3.2) the per-capita disposable income of local urban residents in 2011, or 62.9 times (IQR 40.3--72.1) times the per-capita health expenditure local urban residents in 2011.

Discussion {#sec016}
==========

This report summarizes the situation of the most advanced neonatal medicine in 28 of 31 provincial districts in mainland China, which accounts for 96% of the population of mainland China, with a discharge of 465,629 newborn inpatients in three consecutive years. We have collected comprehensive information through a national baseline database that includes indicators such as health investment, workforce, health care practice, and disease expenditure.

Progress in neonatal medicine in China {#sec017}
--------------------------------------

China has made great progress in neonatal medicine in the last 30 years. Since the first NICU was established in Hangzhou, China in 1983, when there were only four NICU beds \[[@pone.0169970.ref030]\], neonatal medicine has been thriving in China\[[@pone.0169970.ref011], [@pone.0169970.ref013], [@pone.0169970.ref014]\]. Due to the availability of medical equipment such as ventilators, vital sign monitors, incubators, together with the progress in newborn nutrition, imaging and surgery, some level III hospitals in China can implement neonatal clinical technologies conducted in advanced countries\[[@pone.0169970.ref011], [@pone.0169970.ref031]\]. And cutting-edge neonatal technologies have been successfully operated in several hospitals with high success rates, such as extracorporeal membrane oxygenation\[[@pone.0169970.ref032]\]. Accompanied with clinical care, national neonatal education and training programs have been implemented, such as the China Neonatal Resuscitation Program conducted with the Johnson & Johnson Pediatric Institute in the USA\[[@pone.0169970.ref033]\], the Training Program in Neonatal-Perinatal Medicine in Shanghai with the Canadian Neonatal Network\[[@pone.0169970.ref034]\], and the Acute Care of At-Risk Newborns Program in Zhejiang with Canada\[[@pone.0169970.ref035]\]. Jointly, these advances have cumulatively led to the speedy decreases in neonatal, infant and under-5 mortalities in China\[[@pone.0169970.ref003]--[@pone.0169970.ref005], [@pone.0169970.ref007], [@pone.0169970.ref019]\].

Comparisons of survival rates between countries {#sec018}
-----------------------------------------------

A big difference in China exists in the quality of tiny infant care compared with international advanced level. In addition to findings from present study that show 76% of survival rate in ELBW infants from five hospitals, reports from China further show that the survival rate of ELBW infants was 41%, and VLBW infants 82% in 109 hospitals in 2009\[[@pone.0169970.ref011]\], and that VLBW infants with neonatal respiratory failure was 58% in 55 NICUs during 2009--2010\[[@pone.0169970.ref015]\]. These data seem to be comparable with India, where has the similarity of large population size and the survival rate of ELBW infants (52%\[[@pone.0169970.ref036]\] and 56%\[[@pone.0169970.ref037]\] from two NICUs). However, no infants with a birth weight of less than 500 grams or gestational age of less than 25 weeks survived in China before 2011. Although a new neonatal medicine record was established in 2015 that an infant with a birth weight of 500 grams and gestational age of 24 weeks survived in Shenzhen, China\[[@pone.0169970.ref038]\], too many of the sickest newborns cannot receive successful treatments to discharge, with the result of abandonment\[[@pone.0169970.ref015]\]. In contrast, in the advanced international level as the USA, the survival of ELBW infants was approximately 90% during the entire 1990s\[[@pone.0169970.ref039]\], In Japan, the survival rate of birth weight of 750--999 grams was more than 90% in 2005\[[@pone.0169970.ref040]\]. Meanwhile, due to the varieties of gestational age at delivery and birth weight criteria for livebirth registration\[[@pone.0169970.ref041], [@pone.0169970.ref042]\], it is very much possible that the mean birth weight and gestation age of the ELBW infants from this data are larger than that from the reports in Japan\[[@pone.0169970.ref040]\], America\[[@pone.0169970.ref043]\], and Canada\[[@pone.0169970.ref044]\].

Regional discrepancy in China {#sec019}
-----------------------------

The data point to a clear regional discrepancy in neonatal healthcare outcomes ([Fig 2](#pone.0169970.g002){ref-type="fig"}). The report shows the huge differences in access to health services and financial protection across regions in China, such as in antenatal care coverage\[[@pone.0169970.ref045]\]. Reflecting the current socio-economic status of regions in China\[[@pone.0169970.ref021]\], most of the resources, such as high quantify-training professionals, advanced equipment and research funding, are concentrated in some metropolises, especially in the cities of Yangtze River Delta region, Pearl River Delta region, and Bohai Sea Ring Area. This also leads to obvious disproportion in treatment effects and hospital cost as found in this study.

Inadequate investment on health care in China has been long concerned. As found in this study, the total investment of less than 90 million dollars during the three years on the units with the discharge of 465,629 newborn inpatients, illustrates its serious shortage of funds. There are reports describing the serious working environment and shortage of pediatricians and nurses in China\[[@pone.0169970.ref046], [@pone.0169970.ref047]\]. Furthermore, there were no respiratory therapists and NICU social workers, and limited dietitians, pharmacists, and physiotherapists working in the newborn units in this study, in spite of the interdisciplinary nature of the needs of these infants. Another problem is that there is no insurance for newborn diseases in the majority of cities in China\[[@pone.0169970.ref048]\], and that may be one of main causes of withdrawal from treatment. One report about outcomes for very immature newborns in China finds that 46.2% of the deaths from withdrawal of support were associated with the parents' inability to afford the high cost of continued medical treatment\[[@pone.0169970.ref015]\].

Economic impacts of preterm birth {#sec020}
---------------------------------

The expenditures for the treatment of preterm birth in China is much less compared to some high-income countries, but it is expensive compared to the medium Chinese family income. As reported, the length of hospital stay for VLBW infants was 53.7±38.4 days, and the cost was US\$82,900±88,400 in California and New York during early1990s\[[@pone.0169970.ref049]\], but the length of hospital stay for VLBW infants in the USA is longer than that of ELBW infants (median = 49.0 days \[IQR 45.0--58.2\]) in this study, and the cost for VLBW infants in the USA is about ten times the amount of ELBW infants (median = US\$8,613 \[IQR 8,153--9,216\]) in China. The shortage of neonatal health staffs in China, as well as the difference in service quality, partially contribute to this fact. But even so, the cost of ELBW infants in this dataset is three times the per-capita disposable income of local urban residents in China, or 62.9 times of per-capita health expenditure of local urban residents in China. In other words, it costs one and half years' income of a pair of working parents, or 63 personals' health expenditure to successfully discharge an ELBW infant from hospital to home for the first time. This does not include expenditures related to family stay at hospital, and the cost of other diseases resourced from preterm birth. Another report also shows the mean hospital cost of US\$5,586 for preterm infants with gestational age of less than 28 weeks and neonatal respiratory failure during 2004 in China\[[@pone.0169970.ref016]\].

Suggested policies for neonatal medicine in China {#sec021}
-------------------------------------------------

Every Newborn Action Plan issued by The World Health Organization, provides direction for ending preventable newborn deaths worldwide\[[@pone.0169970.ref050]\]. Given current situation in neonatal medicine in China, there are some priorities for the neonatal medical professionals to handle. One of urgent issues to deal with is the standardization and updating of disease management, especially in some critical diseases. In this study, variations in the length of hospital stay and disease expenditure, and the high rates of nosocomial infection and inpatient antimicrobial drug use, suggest inequalities in the provision of healthcare hospitals, cities and regions. More applicable recommendations, clinical guidelines, clinical paths and multidisciplinary cooperation are essential for the successful management and treatment of newborn diseases. In addition, it is important to strengthen continuing education at different levels, and to develop national and regional safety and quality assessment system. A successful example of disease management is The Neonatal Resuscitation Program in China, in which neonatal health care professionals received standard training in 20 target provinces, with 94% of delivery facilities and 99% of counties reached, and the intrapartum-related deaths in the delivery room decreased from 7.5 to 3.4 per 10,000 over a period of five years\[[@pone.0169970.ref033]\].

Study limitations {#sec022}
-----------------

There are some limitations in our study. Though the number of applicants by region and the regional ratios of newborn beds are complied with current population and socioeconomic status in China, there was no population-based sampling, and we relied on administrative data. Although the participating hospitals can be representatives of the highest level of neonatal medicine in China, a couple of hospitals with some strengths have missed this survey. Furthermore, while we summarize the status of advanced neonatal medicine, these results cannot be generalized to primary and secondary neonatal medicine in China. To minimize inaccuracies, we reviewed all the documents and searched well-established databases. We also collected another comprehensive dataset of research and training.

Conclusions {#sec023}
===========

In summary, this study provides a comprehensive baseline picture of neonatal medicine in China and describes a population-based database that can serve as a benchmark not only for further longitudinal and cross-sectional studies, but also provides important information to inform newborn practice and policy.

Supporting Information {#sec024}
======================

###### List of participating hospitals.

(DOCX)
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Click here for additional data file.
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